Nokia Corporation - Managers' transactions (Hammarén)

Nokia Corporation
Managers’ transactions
31 October 2024 at 19:00 EET

Nokia Corporation - Managers' transactions (Hammarén)

Transaction notification under Article 19 of EU Market Abuse Regulation.
____________________________________________
Person subject to the notification requirement
Name: Hammarén, Patrik
Position: Other senior manager

Issuer: Nokia Corporation
LEI: 549300A0JPRWG1KI7U06
Notification type: INITIAL NOTIFICATION
Reference number: 83263/4/4
____________________________________________

Transaction date: 2024-10-31
Outside a trading venue
Instrument type: SHARE
ISIN: FI0009000681
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details
(1): Volume:498 Unit price: N/A

Aggregated transactions
(1): Volume: 498 Volume weighted average price: N/A

About Nokia
At Nokia, we create technology that helps the world act together.

As a B2B technology innovation leader, we are pioneering networks that sense, think and act by leveraging our work across mobile, fixed and cloud networks. In addition, we create value with intellectual property and long-term research, led by the award-winning Nokia Bell Labs.

With truly open architectures that seamlessly integrate into any ecosystem, our high-performance networks create new opportunities for monetization and scale. Service providers, enterprises and partners worldwide trust Nokia to deliver secure, reliable and sustainable networks today – and work with us to create the digital services and applications of the future.

Inquiries:

Nokia Communications
Phone: +358 10 448 4900
Email: [email protected]
Maria Vaismaa, Global Head of External Communications

Nokia
Investor Relations
Phone: +358 40 803 4080
Email: [email protected]

You May Also Be Interested In

• SayRose Introduces a New Era of Aesthetic Technology Gifts at IFA 2026
• TRON Keeps Altcoin Momentum Alive as IceBull Adds a Stage 1 Entry Before 15 Higher Prices in the 100x Crypto Race
• Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings